Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Kavanagh, M.E.; Gray, J.L.; Gilbert, S.H.; Coyne, A.G.; McLean, K.J.; Davis, H.J.; Munro, A.W.; Abell, C.
    Substrate fragmentation for the design of M. tuberculosis CYP121 inhibitors (2016), ChemMedChem, 11, 1924-1935 .
    View publication on PubMedView publication on EuropePMC

Application

EC Number Application Comment Organism
1.14.19.70 medicine the CYP121 gene is essential for survival of Mycobacterium tuberculosis in vitro and the enzyme is believed to be the molecular target responsible for the anti-tubercular efficacy of azole antifungal compounds pharmacology Mycobacterium tuberculosis

Inhibitors

EC Number Inhibitors Comment Organism Structure
1.14.19.70 additional information the cyclo-dipeptide substrates of the essential Mycobacterium tuberculosis enzyme CYP121 are deconstructed into their component fragments and screened against the enzyme Mycobacterium tuberculosis

Organism

EC Number Organism UniProt Comment Textmining
1.14.19.70 Mycobacterium tuberculosis P9WPP7
-
-

Synonyms

EC Number Synonyms Comment Organism
1.14.19.70 CYP121
-
Mycobacterium tuberculosis